Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:40 AM UTC
| NCT Number | NCT05543681 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 164 participants |
| Active Locations | 16 sites in the US |
| Sponsor | IGC Pharma, LLC |
| Last Updated on CT.gov | April 14, 2026 (3 days ago) |
As of April 17, 2026: Clinical trial NCT05543681 is currently recruiting participants. This clinical trial study for alzheimer's disease is actively seeking new participants at 16 locations across the United States. The study is sponsored by IGC Pharma, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05543681 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05543681 was last updated 3 days ago (April 14, 2026). HelloStudys verifies this status automatically.